![]() | |
Names | |
---|---|
Systematic IUPAC name 1-(Benzo[d][1,3]dioxol-5-yl)-2-(dimethylamino)butan-1-one | |
Other names 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)butan-1-one; β-Keto-dimethylbenzodioxolylbutanamine; bk-DMBDB | |
Identifiers | |
3D model (JSmol) | |
ChemSpider | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
| |
| |
Properties | |
C13H17NO3 | |
Molar mass | 235.283 g·mol−1 |
Pharmacology | |
Legal status |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
Dibutylone (bk-DMBDB [2] ) is a stimulant drug of the amphetamine, phenethylamine, cathinone, and phenylisobutylamine families. It is structurally related to butylone, a designer drug that has been detected in products marketed as bath salts or plant food. [3]
In 2018, dibutylone was the third most common drug of the cathinone class to be identified in Drug Enforcement Administration seizures. [4]
In United States, dibutylone is on the list of Schedule I Controlled Substances as a positional isomer of pentylone. [5]